Interpretation of conventional survival analysis and competing-risk analysis: an example of hypertension and prostate cancer

BJU Int. 2016 Dec;118(6):850-852. doi: 10.1111/bju.13494. Epub 2016 Apr 24.

Christel Häggström^{1

2

3}, Pär Stattin^{1

2}, Tanja Stocks^{1

4}, Hans Garmo^{5

6}, Lars Holmberg^{5

6}, Mieke Van Hemelrijck^{6

7}

¹ Department of Surgical and Perioperative sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
² Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
³ Department of Biobank Research, Umeå University, Umeå, Sweden.
⁴ Department of Clinical Sciences, Diabetes and Cardiovascular Diseases, Genetic Epidemiology, Lund University, Lund, Sweden.
⁵ Regional Cancer Centre Uppsala/Örebro, Uppsala, Sweden.
⁶ King's College London, Faculty of Life Sciences and Medicine, Division of Cancer Studies, London, UK.
⁷ Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.

No abstract available

Publication types